![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ERRATUM article
Front. Pharmacol. , 30 May 2022
Sec. Pharmacology of Anti-Cancer Drugs
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.937601
This article is an erratum on:
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma
by Colapietro, A., Yang, P., Rossetti, A., Mancini, A., Vitale, F., Chakraborty, S., Martellucci, S., Marampon, F., Mattei, V., Gravina, G. L., Iorio, R., Newman, R. A., and Festuccia, C. (2022). Front. Pharmacol. 13:852941. doi: 10.3389/fphar.2022.852941
Due to a production error, an author name was incorrectly spelled as “Stefano Martelluci”. The correct spelling is “Stefano Martellucci”.
The publisher apologizes for this mistake. The original version of this article has been updated.
Keywords: glioblastoma, radiotherapy, PBI-05204, apoptosis, oleandrin, DNA repair
Citation: Frontiers Production Office (2022) Erratum: The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, is Synergistic With Radiotherapy in Models of Human Glioblastoma. Front. Pharmacol. 13:937601. doi: 10.3389/fphar.2022.937601
Received: 06 May 2022; Accepted: 06 May 2022;
Published: 30 May 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.